Facebook Pixel Local manufacturing is not just a priority— it is a national commitment | Express Pharma - health - Lees dit verhaal op Magzter.com
Ga onbeperkt met Magzter GOLD

Ga onbeperkt met Magzter GOLD

Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts

$149.99
 
$74.99/Jaar

Poging GOUD - Vrij

Local manufacturing is not just a priority— it is a national commitment

Express Pharma

|

January 2026

Frehiwot Abebe, State Minister, Ministry of Health, Ethiopia, and Bhavin Mukund Mehta, Vice Chairman, Pharmexcil, discuss Ethiopia's evolving pharma ecosystem.

Local manufacturing is not just a priority— it is a national commitment

They outline the country's regulatory reforms, strategies to strengthen local manufacturing, investment- friendly policies, and future plans for capacity building and vaccine development. The conversation also highlights the growing India-Ethiopia partnership, with insights from Pharmexcil on export trends, regulatory alignment, and improving the ease of doing business

Ethiopia is undergoing significant evolution in its pharma regulatory landscape. What are the most critical regulatory reforms underway, and how do you envision international partners contributing to this transformation?

Frehiwot Abebe: Ethiopia, with a population of over 130 million, is currently reforming its local pharmaceutical manufacturing sector. More than 85 per cent of our pharma are imported, so our visit to India had two main objectives: first, to learn from India's journey in becoming a global pharma hub, and second, to promote investment opportunities in Ethiopia.

Strengthening the regulatory framework has been essential. Over the past two to three years, we have worked continuously with the World Health Organisation to meet global regulatory benchmarks. Recently, we achieved Maturity Level 3 for pharma products, which indicates that our regulatory system is now stable, reliable, and supportive of local manufacturing and export.

To create a more responsive regulatory environment, we assessed our challenges—particularly delays in responsiveness and communication. We have now digitised the entire system, enabling companies to apply online for product registration and submit all required documentation electronically.

India accounts for more than 70 per cent of our pharma imports, so during our visit we sought feedback directly from Indian investors. Some challenges they highlighted included delays in GMP inspections. We have already begun working on improving the speed and efficiency of GMP assessments.

MEER VERHALEN VAN Express Pharma

Express Pharma

Express Pharma

Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?

Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing

time to read

5 mins

May 2026

Express Pharma

Express Pharma

Ensuring Pharma compliance with testo data measurement technology

Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

China+1 moment for pharma: How India can convert opportunity into long-term contracts

Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Beyond scale: Rethinking new frontiers in building excellence

At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports

time to read

10 mins

May 2026

Express Pharma

Express Pharma

Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR

Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement

time to read

2 mins

May 2026

Express Pharma

Express Pharma

JNPC: Carrying forward a 20-year old legacy

Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Romaco's sustainable blister packaging line at interpack

At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.

time to read

6 mins

May 2026

Express Pharma

Express Pharma

Even drug-resistant cancer targets can be tackled with the right design strategy

Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma

time to read

7 mins

May 2026

Express Pharma

Express Pharma

Navigating legal and regulatory landscape of GLP-1 drugs in India

GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders

time to read

5 mins

May 2026

Express Pharma

Express Pharma

From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India

Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact

time to read

4 mins

May 2026

Listen

Translate

Share

-
+

Change font size